End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.24 CNY | -0.36% | -6.40% | -17.99% |
Jun. 20 | Nhwa Pharmaceutical's Penehyclidine Hydrochloride Injection Passes Regulatory Testing | MT |
Jun. 20 | Nhwa Pharmaceutical Gets Registration Certificate for Pregabalin Capsules | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.99% | 3.1B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- 002262 Stock
- News Jiangsu Nhwa Pharmaceutical Co., LTD
- Jiangsu Nhwa Pharma’s Q1 Profit Jumps 20.5% as Revenue Rises 19%; Shares Jump 5%